Undifferentiated Pleomorphic Sarcoma Recurrence Observed two months Postoperatively in Case Report of Gastric Mass
Cancer returns quickly after surgery and chemo for a 71-year-old woman
This case report and literature review describes a 71-year-old female with undifferentiated pleomorphic sarcoma treated with R0 resection, s…
A 71-year-old woman with rare stomach tumors had surgery and chemo, but the cancer came back just two months later.
Adjuvant Imatinib Beyond 3 Years in High-Risk GIST: 5-Year Relapse-Free Survival Outcomes
Extending Imatinib beyond 3 years did not improve survival for high-risk GIST patients.
This retrospective cohort study evaluated adjuvant imatinib duration in 75 patients with high-risk GIST after radical surgery. Extending the…
A look at past data shows taking Imatinib longer than three years did not help high-risk GIST patients live longer or stay cancer-free.
Meta-analysis identifies germline susceptibility loci for rare cancers including MDS and GIST.
Genes linked to rare cancers found in large study of over 480,000 people
This meta-analysis of observational cohorts from over 480,000 individuals identified novel germline susceptibility loci for rare cancers. Ke…
A huge study of over 480,000 people found new genes that raise the risk of several rare cancers, offering clues for families and doctors.